Ahmad Halawa, MD

Dr. Ahmad Halawa is a cardiac electrophysiologist at Robert Wood Johnson Hospital. He graduated from the University of Aleppo Faculty of Medicine and completed his residency training at East Tennessee State University, followed by specialized training in cardiovascular disease at the University of Missouri-Columbia. Later, he completed an advanced fellowship in Cardiac Electrophysiology at the Harvard Medical School/Brigham and Women's Hospital.

Dr. Halawa specializes in the diagnosis and treatment of complex cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, SVT, and bradycardia. He performs electrophysiology studies, catheter ablation for atrial and ventricular arrhythmias, and implantation of cardiac devices, including implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and leadless pacemakers. He is involved in research and has published in peer-reviewed journals on arrhythmia management, sudden cardiac death prevention, and device therapy in cardiac conditions.

Previously, Dr. Halawa served as an assistant professor of medicine at Creighton University School of Medicine, where he contributed to clinical excellence, research, and education. He is a member of the Heart Rhythm Society and the American College of Cardiology and has been an invited speaker at national conferences.

1. Uyanga Batnyam, Kamen V Vlassakov, Ahmad Halawa, Erica Seligson; Brigham Regional Anesthesia Group (BRAG); Liting Chen, Brahim Redouane, David Janfaza and Usha B Tedrow. Safety and Efficacy of Ultrasound-Guided Sympathetic Blockade by Proximal Intercostal Block in Electrical Storm Patients. JACC Clin Electrophysiol. 2024 Apr;10(4):734-746.

3. Bains K, Janfaza D, Flaherty D, Zeballos J, Halawa A, Tedrow U, Vlassakov K. Sympathetic Blockade for the Management of Refractory Ventricular Tachycardia: A Case Report. A A Pract. 2021 Apr 21;15(4): e01456. PMID: 33882033.

4. Dherange P, Sauer W, Halawa A, Qian P, Kapur S, Zei P, Cochet H, Blankstein R,Tedrow U. Intracardiac Impedance: A Novel Marker for Computed Tomography Derived Wall Thinning in Ventricular Tachycardia Ablation. JACCEP. JACC Clin Electrophysiol. 2020 Oct 26;6(11):1465-1466. PMID: 33121676.

5. Qian PC, Halawa A, Sauer WH, Tedrow UB, Sweeney MO, Zei P. A Maze-ing crisscross interval plot: what is the diagnosis? Europace. 2020 Aug 1;22(8):1233. PMID: 32607580.

6. Halawa A, Martin A, Sweeney M, and Kapur S. Syncope after successful implantation of atrioventricular synchronous leadless pacemaker caused by polymorphic ventricular tachycardia. Heart rhythm case reports. 2020 May 18;6(8):503-506. PMID:32817828.

7. Halawa A, Woldu HG, Kacey KG, Alpert MA. Effect of ICD implantation on cardiovascular outcomes in patients with cardiac amyloidosis: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2020 Jul;31(7):1749-1758. PMID: 32391952.

8. Halawa A, Jain R, Turagam MK, Kusumoto FM, Woldu HG, Gautam S. Outcome of implantable cardioverter defibrillator in cardiac sarcoidosis: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2020 Aug;58(2):233-242. PMID: 32062788

9. Rugheed Ghadban MD, Tariq Enezate MD, Joshua Payne MD, Haytham Allaham MD, Ahmad Halawa MD, Hee Kong Fong MD, Obai Abdullah MD, Kul Aggarwal MD. The Safety of Morphine Use in Acute Coronary Syndrome: A Meta-analysis. Heart Asia. 2019 Mar 19;11(1): e011142. PMID: 31031833

10. Halawa A, Dave I, Gautam S. Torsade de Pointes with severe vitamin D deficiency, an unusual presentation of a common problem. J Cardiol Cases. 2019;20(4):132-134. PMID: 31969942

11. Ahmad Halawa MD, Tariq Enezate MD, Greg Flaker MD. Device Monitoring in Heart Failure Management: Outcomes Based on a Systematic Review and Meta-analysis. Cardiovasc Diagn Ther. 2019;9(4):386-393. PMID:31555544

12. Ahmad Halawa MD and Sandeep Gautam MD, FHRS. T wave Oversensing in Subcutaneous Implantable Cardioverter Defibrillator Secondary to Hematoma formation: A Potential Cause of Early Post-Implantation Inappropriate Shocks. J Arrhythm. 2019 Feb; 35(1): 130–132. PMID:30805053

13. Halawa A, Burton C, Maniaci M and Dawson N. Association of Anemia with Outcomes of Acute Heart Failure. South Med J. 2018 Feb;111(2):103-108. PMID: 29394427

14. Mueller JA1, Patel T, Halawa A, Dumitrascu A, Dawson NL. Warfarin dosing and body mass index. Ann Pharmaco ther. 2014, May; 48(5): 584-8. Cited in PubMed; PMID: 24558184.

15. Halawa A, Henry PD, Sarubbi FA. Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines. Mycoses. 2011, Jul; 54(4): 168-74. Cited in PubMed; PMID: 21672037.

16. Kosseifi SG, Halawa A, Bailey B, Micklewright M, Roy TM, Byrd RP Jr. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Ther Adv Respir Dis. 2009, Dec; 3(6): 289-94. Cited in PubMed; PMID: 19850648.

17. Halawa A, Brahmbhatt V, Fahrig SA. Initial description of radiofrequency catheter ablation as treatment for atrial flutter in Marfan's syndrome: a case report and literature review. J Interv Card Electrophysiol. 2007, Jun; 19(1): 37-40. Cited in PubMed; PMID: 17597390.

18. Halawa A, Iskandar SB, Brahmbhatt V, Fahrig SA. Atrial flutter and myotonic dystrophy in a male adolescent treated with radiofrequency catheter ablation. Rev Cardiovasc Med. 2007, Mar; 8(2): 118-22. Cited in PubMed; PMID:17603429.

19. Halawa A, Iskandar S, Garcia I. Constrictive pericarditis after coronary artery bypass. Rev Cardiovasc Med. 2006, Sep; 7(4): 238-43. Cited in PubMed; PMID: 17224867.

Peer Reviewed Book Chapter

1. Negi. S, Halawa. A, Chi.D.S, Miller.C, Hossler.F.E, Youngberg.G, Johnson.D.A, Krishnaswamy.G. (2010). Mast Cell Regulation of Cardiovascular Inflammation II: Infection and Innate Immunity. In J.Joseph (Ed.), Mast Cells and Cardiovascular Disease (pp. 63-88). Hauppauge: Nova Science Publishers.

2. Negi. S, Halawa. A, Chi.D.S, Miller.C, Hossler.F.E, Youngberg.G, Johnson.D.A, Krishnaswamy.G. (2010). Mast Cell Regulation of Cardiovascular Inflammation I: Cognate and Non-Cognate Interactions. In J.Joseph (Ed.), Mast Cells and Cardiovascular Disease (pp. 32-62). Hauppauge: Nova Science Publishers Inc.

 Medical School

University of Aleppo Faculty of Medicine, Aleppo, Syria (2001)

East Tennessee State University  (Internal Medicine - 2006)

University of Missouri-Columbia   (Cardiovascular Disease - 2019)

Harvard Medical School/ Brigham and Women’s Hospital  (Cardiac Electrophysiology - 2021)